B
Barbara Wollenberg
Researcher at Technische Universität München
Publications - 195
Citations - 2893
Barbara Wollenberg is an academic researcher from Technische Universität München. The author has contributed to research in topics: Medicine & Head and neck squamous-cell carcinoma. The author has an hindex of 25, co-authored 142 publications receiving 2384 citations.
Papers
More filters
Journal Article
Simultaneous Activation of T Cells and Accessory Cells by a New Class of Intact Bispecific Antibody Results in Efficient Tumor Cell Killing
Reinhard Zeidler,Gilbert Reisbach,Barbara Wollenberg,Stephan Lang,S. Chaubal,Bärbel Schmitt,Horst Lindhofer +6 more
TL;DR: It is demonstrated here that the activation of both T lymphocytes and accessory cells leads to production of immunomodulating cytokines like IL-1beta,IL-2, IL-6, Il-12, and DC-CK1, and therefore this new class of bsAb elicits excellent antitumor activity in vitro even without the addition of exogenous IL-2.
Journal ArticleDOI
Cytokines in head and neck cancer
Ralph Pries,Barbara Wollenberg +1 more
TL;DR: The better understanding of secretion and regulation pathways of immune suppressive and proangiogenic cytokines in HNSCC is essential to increase the clinical perspective of this tumor type with respect to an immunomodulatory intervention in patients with HNS CC.
Journal ArticleDOI
Application of the Vibrant Soundbridge to unilateral osseous atresia cases.
Henning Frenzel,Frauke Hanke,Millo Beltrame,Armin Steffen,Rainer Schönweiler,Barbara Wollenberg +5 more
TL;DR: The objective of this research is to evaluate the active middle ear implant, the Vibrant Soundbridge® (VSB), for hearing rehabilitation of patients with unilateral osseous aural atresia.
Journal ArticleDOI
Isolation and Characterization of Adult Stem Cells from Human Salivary Glands
Nicole Rotter,Jessica Oder,Peter Schlenke,Ulrich Lindner,Florian Böhrnsen,Jan Kramer,Jürgen Rohwedel,Ralph Huss,Sven Brandau,Barbara Wollenberg,Stephan Lang +10 more
TL;DR: This study is the first report on the isolation and differentiation of stem cells from adult human parotid glands that share many characteristics with MSCs, and makes salivary gland-derived stem cells a promising source for future applications in regenerative medicine.
Journal ArticleDOI
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha.
Isabelle Bekeredjian-Ding,Meike Schäfer,Evelyn Hartmann,Ralph Pries,Marijo Parcina,Philip Schneider,Thomas Giese,Stefan Endres,Barbara Wollenberg,Gunther Hartmann,Gunther Hartmann +10 more
TL;DR: It is demonstrated that tumour‐derived prostaglandin E2 (PGE2) and transforming growth factor‐β (TGF‐β) increase interleukin‐8 (IL‐8) but synergistically inhibit interferon‐α (IFN‐α) and tumour necrosis factor (TNF) production of Toll‐like receptor 7 (TLR7)‐ and Toll‐ like receptor 9 (TLr9)‐stimulated PDC.